To be Hong Kong’s leading healthcare and life sciences investment enterprise.
Endurance RP is a dynamic investor focused on growing long term-value and delivering superior returns to stakeholders.
Its aim is to build a portfolio of late-stage healthcare and life sciences-related investments and commercialise them through ‘out-licensing’ to other strategic pharmaceutical partners. With this approach, Endurance RP seeks to deliver significant dividends to shareholders from royalty receipts, and/or selling to large pharmaceutical companies.
Through prudent investment management, the company strives to distribute surplus cash to its shareholders by way of an effective dividend policy and/or share repurchase programme.